# Safety Study of an Additional MVA Vaccine in Volunteers Who Received 3 DNA Vaccines Followed by 2 MVA Vaccines

> **NCT01461447** · PHASE1,PHASE2 · COMPLETED · sponsor: **Muhimbili University of Health and Allied Sciences** · enrollment: 20 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **BIOLOGICAL:** Modified Vaccinia Ankara

## Key facts

- **NCT ID:** NCT01461447
- **Lead sponsor:** Muhimbili University of Health and Allied Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2012-05-24

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01461447

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01461447, "Safety Study of an Additional MVA Vaccine in Volunteers Who Received 3 DNA Vaccines Followed by 2 MVA Vaccines". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01461447. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*